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A WNT/b-CATENIN NEGATIVE FEEDBACK LOOP INHIBITS IL-1b
INDUCED MMP EXPRESSION IN HUMAN ARTICULAR CHONDROCYTES
B. Ma, C.A. van Blitterswijk, M. Karperien. Univ. of Twente, Enschede,
Netherlands
Purpose: Recent animal studies suggest that activation of Wnt/b-catenin
signaling in articular chondrocytes might be a driving factor in the path-
ogenesis of osteoarthritis (OA) by stimulating amongst others the
expression of matrix metalloproteinases (MMPs). Indeed in animal chon-
drocytes IL-1b induced MMP expression is mediated by activation of
canonical Wnt/b-catenin signaling. This study aimed to investigate the role
of Wnt/b-catenin signaling in IL-1b induced MMP expression in human
chondrocytes.
Methods: Primary cultures of human articular chondrocytes derived from
post mortem healthy donors or patients with end stage osteoarthritis or
rheumatoid arthritis were used in all experiments. Cells were stimulated
with recombinant growth factors and cytokines. Changes in gene and
protein expression were studied using qPCR, Western blot, and enzymatic
essays. Multiple strategies for activation and inhibition of signaling path-
ways in human chondrocytes, such as lentiviral mediated gene over-
expression or gene knock down were used. Luciferase reporter assays and
co-immunoprecipitation essays were used to study the interaction
between b-catenin and NF-kB.
Results: IL-1b potently stimulated MMP1, -3 and -13 expression in
human and murine chondrocytes dose-dependently. In marked contrast,
co-stimulation with the recombinant Wnt3A, which activates canonical
Wnt/b-catenin signaling, potently inhibited IL-1b induced MMP dose-
dependently in human chondrocytes but not in murine chondrocytes.
This inhibitory effect was found in human chondrocytes irrespective of
the disease state of the donor being either healthy, osteoarthritic or
rheumatoid arthritic and was also found in human bone marrow derived
mesenchymal stem cells. In contrast, Wnt/b-catenin signaling induced
MMP expression in chondrocytes of all animal species tested, revealing
an unprecedented species difference. Wnt3A's inhibitory effect was
found in both basal conditions and after IL-1b stimulation at the mRNA
level, protein level and in enzymatic essays. Wesetern blot indicated that
IL-1b indirectly activated b-catenin in human chondrocytes. This was
due to IL-1b induced upregulation of the canonical Wnt7B and down
regulation of the Wnt-signaling antagonists DKK1, Wif1 and FRZb as
demonstrated by gene knock down and gene overexpression studies. The
inhibitory effect of Wnt3A on IL-1b induced MMP expression was
independent of TCF/LEF transcription factors, since knock down of TCF4
did not alter Wnt3A's effect. This was in marked contrast to murine
chondrocytes in which knock down of TCF4 completely blocked IL-1b
induced MMP expression. Subsequently, we showed that the inhibitory
effect on IL-1b induced MMP expression in human chondrocytes was
due to an inhibitory protein-protein interaction between b-catenin and
NF-kB/p65RELA blocking the activation of NF-kB promoter reporter
constructs as well as inhibiting the expression of established NF-kB
target genes like IL-6.
Conclusions: Our study reveals an unexpected and unprecedented
species difference between human and animal chondrocytes with respect
of the role of Wnt/b-catenin signaling in the regulation of MMP expres-
sion. In marked contrast to mouse chondrocytes in which Wnt/b-catenin
signaling is part of an IL-1b activated pro-catabolic sequence resulting in
increased MMP expression, in human cells b-catenin has an unexpected
anti-catabolic role. We provide evidence that Wnt/b-catenin signaling is
part of an IL-1b activated negative feedback loop involving upregulation
of the canonical Wnt7B and down regulation of established Wnt-antag-
onists like DKK1. This leads to activation of b-catenin, which in turn
inhibits NF-kB activity due to an inhibitory protein-protein interaction
with p65RELA. Our results question the relevance of animal models for
studying the role of Wnt/b-catenin signaling in osteoarthritis. They
furthermore imply that upregulated b-catenin in human osteoarthritic
cartilage may be part of an anti-catabolic response counteracting pro-
catabolic NF-kB signaling.256
BMP-9 INDUCES BOTH SMAD1/5/8 AND SMAD2/3 PHOSPHORYLATION,
AND SPECIFIC RESPONSE GENES, IN CHONDROCYTES
A. van Caam, E. Blaney Davidson, E. Vitters, W. van den Berg, P. van der
Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Background: Osteoarthritis is characterized by loss of articular cartilage.
The main cartilage degrading enzyme is Matrix metalloproteinase 13
(MMP13). Expression of MMP13 is positively correlated with Activin
receptor-like kinase 1 (ALK1) expression. Moreover, terminal differentia-
tion of chondrocytes is induced by ALK1 via phosphorylation of Smad1/5/8
(Smad1/5/8p). BMP-9, also known as GDF-2, has recently been character-
ized as a potent, high-afﬁnity ALK1 ligand, that is present in serum in high
amounts . We wanted to further investigate intracellular BMP-9 signaling
in chondrocytes to clarify its role in cartilage maintenance and
degradation.
Purpose: To study Smad1/5/8 and Smad2/3 phosphorylation kinetics in
response to addition of exogenous BMP-9, to investigate BMP-9’s potency
on chondrocytes, and to investigate downstream signaling responses on
mRNA level.
Methods: Both primary bovine chondrocytes, isolated from the meta-
carpophalangeal joint of 2 year old animals, as well as the murine H4
chondrocyte cell line were used in this study. Chondrocytes were cultured
to near conﬂuency, and subsequently incubated with BMP-9. After short
term stimulation (1 h), Smad phosphorylation was analyzed by speciﬁc
Smad2/3p and Smad1/5/8p staining of Western blots. After long term
stimulation (24-48 h), expression of PAI-1, a downstream marker of
Smad2/3 signaling, and ID-1, a downstream marker of Smad1/5/8
signaling, were analyzed by quantitative real time PCR (qPCR).
Results: In both the murine cell line, as well as the primary bovine
chondrocytes, addition of BMP-9 resulted in phosphorylation of Smad 1/5/
8, that was maximal at very low concentrations (100 pg / ml). Unexpect-
edly, Smad2/3p was also observed at this concentration. Further investi-
gations showed that BMP-9-induced Smad2/3p was maximal after 1 h, at
the physiological relevant concentration of 5 ng/ml. Exposure of chon-
drocytes to BMP9 not only resulted in both Smad1/5/8p and Smad2/3p but
also in transcription of pathway speciﬁc response genes, as observed by
a signiﬁcant increase in PAI-1 and ID-1 mRNA levels after both 24 and 48h.
In both cell types, collagen type 2A1 and aggrecan mRNA levels were also
up regulated by BMP9. In the described experiments, no signiﬁcant
changes in MMP13 expression were observed after 48 h of BMP-9
stimulation.
Conclusion: In chondrocytes, BMP9 is capable of inducing both Smad1/5/
8p and Smad2/3p. By doing so it can up regulate both PAI-1 and ID-1
simultaneously. BMP-9 is very potent in inducing Smad phosphorylation,
as very low concentrations (pg/ml) are sufﬁcient for signal induction. The
induction of Smad2/3p and subsequent PAI-1 activity sets BMP-9 apart
from other BMPs, like BMP-2 and BMP-6, that only induce Smad1/5/8
phosphorylation. The lack of MMP13 expression after BMP-9 stimulation
can be explained by the induced Smad2/3p expression, as this potently
blocks MMP13 transcription. Based on these results we propose that
exposure of young cartilage to BMP-9 does not result in MMP13 expression
due to its ability to induce Smad2/3p. However, we previously reported
that in ageing cartilage the ability to phosphorylate Smad2/3 is reduced,
and therefore BMP-9 exposure will most likely result in MMP13 produc-
tion in old cartilage.
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A TYPE II COLLAGEN PEPTIDE ACTIVATES P38 MITOGEN-ACTIVATED
PROTEIN KINASE AND ITS INHIBITION BY HYALURONAN VIA ICAM-1
IN ARTICULAR CHONDROCYTES
T. Yasuda. Tenri Univ., Tenri, Japan
Background: Some proteolytic products of cartilage matrix may
contribute to cartilage destruction through their catabolic activities.
Recently, we have found that a 24-mer synthetic peptide of type II collagen
named CB12-II stimulates type II collagen cleavage with induction of
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S134matrix metalloproteinase (MMP)-13 in cartilage explant culture. Although
the intracellular signaling that leads to cartilage destruction is mediated by
a cluster of catabolic pathways including mitogen-activated protein
kinases (MAPKs), the effect of CB12-II on MAPK pathways remains unclear.
Hyaluronan (HA) of high molecular weight is widely used in the treatment
of osteoarthritis (OA) by intra-articular injection. An increasing body of
evidence indicates that HA suppresses catabolic actions by proin-
ﬂammatory cytokine like interleukin-1. However, little is known of HA
effect on actions of CB12-II through interaction with HA receptor such as
intercellular adhesion molecule-1 (ICAM-1).
Purpose: This study was aimed to examine activation of p38 MAPK in
associationwith MMP-13 production by CB12-II and its inhibition by HA in
chondrocytes.
Methods: Cartilage explants harvested from OA knee joints or isolated
chondrocytes in monolayer were incubated with CB12-II or its scramble
peptide with or without pretreatment with 2700 kDa HA. In another set of
experiments, following preincubation with anti-ICAM-1 antibody or non-
speciﬁc IgG, cartilage explants were incubated with or without HA, fol-
lowed by coincubation with CB12-II or the scramble peptide.
Enzyme-linked immunosorbent assay for phosphorylated p38 and MMP-
13 was performed using total cell lysates and culture supernatants,
respectively.
Results: When cartilage explants or chondrocytes in monolayer were
incubated with CB12-II, the peptide activated p38 in association with
enhanced MMP-13 production. Inhibition studies with the speciﬁc inhib-
itor (SB203580) indicated the requirement of p38 for CB12-II-induced
MMP-13 production. Pretreatment with HA resulted in signiﬁcant
suppression of CB12-II-stimulated MMP-13 production in cartilage as well
as in chondrocyte monolayer cultures. HA suppressed p38 activation by
CB12-II, leading to a decrease in MMP-13 production. Anti-ICAM-1 anti-
body reversed HA effect on CB12-II action.
Conclusions: The present study clearly demonstrated that HA suppressed
CB12-II-activated p38 via ICAM-1 in OA articular chondrocytes. HA could
down-regulate the catabolic action of type II collagen fragments in oste-
oarthritic joints through the mechanism demonstrated in this study.
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IDENTIFICATION OF NEW ALTERNATIVE PATHWAYS AND THERAPEUTIC
TARGETS IN TNF-a-MEDIATED INFLAMMATION AND OSTEOLYSIS
INDUCED BY ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE
Z. He 1, D.J. Leong 1, R.J. Majeska 2, J.A. Hardin 1, N.J. Cobelli 1,
H.B. Sun 1. 1Albert Einstein Coll. of Med., Bronx, NY; 2 The City Coll. of New
York, New York, NY, USA
Purpose: Osteolysis is the most common cause of failure for joint
replacement surgeries. Wear debris of prosthetic implants provoke
inﬂammatory responses, leading to osteoclast differentiation, osteolysis
and ultimately, implant loosening. Debris from implants, including ultra-
high molecular weight polyethylene (UHMWPE), one of the most common
materials used in arthroplasty, induce a variety of inﬂammatory responses,
including increased secretion of pro-inﬂammatory cytokine TNF-a (Tumor
necrosis factor alpha). A large body of literature has established the critical
role of TNF-a in UHMWPE-induced inﬂammation and osteolysis,
predominantly mediated via the RANKL/NF-kB pathway. However,
extensive efforts to prevent and treat prosthetic wear-induced osteolysis
by interfering with the TNF-a-associated RANKL/NF-kB pathway has seen
limited success. This suggests the existence of alternative pathways for
TNF-a-mediated inﬂammation and osteolysis. Accordingly, in the current
studies, we explored alternative molecular pathways by which TNF-a
might mediate inﬂammation and osteolysis induced by UHMWPE.
Methods: Osteoclast differentiation induction, UHMWPE treatment and
TNF-a inhibition: Bone marrow was harvested from TNF-a knockout and
wild-type C57/BL6 mice (Jackson Laboratories) according to our IACUC-
approved protocol and cultured. Marrow cells were induced for osteoclast
differentiation by M-CSF and RANKL. After 2 days of differentiation
induction, the cells were treated with UHMWPE particles (53-75mm,
Sigma) alone or with TNF-a inhibitor Inﬂiximab (Centocor Biotech). For
some experiments, cultures were treated with NF-kB inhibitor for 72 hrs
(Santa Cruz). Cellular and molecular assays: The cells were harvested for
qPCR and Western blot to measure targeted gene expression, or subject toTRAP staining (kit from Clontech) to determine osteoclast differentiation.
Cells without UHMWPE treatment were used as controls.
Results: Exposure to UHMWPE promotes differentiation of wild-type
marrow cells to osteoclasts (increased number of TRAP-positive osteoclast-
like cells), increases expression of TNF-a, TNF-a receptor 1 (TNF-aR1), and
multiple TNF targets including Snail1 and survivin in these cells, over
control (non-UHMWPE-treated) cultures. UHMWPE exposure fails to
enhance osteoclast differentiation, or increase expression of TNF receptor
or its downstream targets in TNF-a knockout cells, conﬁrming the critical
mediating role of TNF-a in UHMWPE-induced inﬂammation and osteol-
ysis. Interestingly, TNF inhibitor-a Inﬂiximab suppresses the osteoclast
differentiation and the upregulated expression of factors induced by
UHMWPE treatment in wild type cell culture; however, the UHMWPE
upregulated expression of Snail1 and survivin appeared not affected by
NF-kB inhibition.
Conclusions: Our results, in addition to substantiating the critical role of
TNF-a in UHMWPE-induced inﬂammation and osteolysis, identiﬁed
several downstream targets of TNF-a that are activated in response to
UHMWPE but are beyond the NF-kB pathway typically implicated in
osteoclastogenesis. These TNF-a targets have been shown to serve
important and relevant functions. Snail1 is critical for inﬂammatory-
induced cell migration, and survivin is an apoptosis inhibitor. Our results,
although preliminary, provide evidence of alternative pathway/factors in
addition to NF-kB through which TNF-a mediates UHMWPE-induced
inﬂammation and osteolysis. Our results are supported by recent reports of
TNF-a’s involvement in regulation of some signaling molecules, whose
expressions are not directly regulated by NF-kB. Further elucidation of
these alternative pathways will faciliate our understanding of the osteo-
lytic process induced by UHMWPE. The identiﬁcation of new TNF-a targets
may also promote prevention and treatment of osteolysis and the conse-
quent implant loosening induced by UHMWPE.
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THE EFFECT OF HIGH MOLECULAR HYALURONIC ACID ON THE
INDUCTION OF MATRIX DEGRADATION ENZYMES BY IL-6, IL-1b AND
TNF-a
M. Mihara, M. Hashizume. Chugai Pharmaceutical Co., Ltd, Gotemba, Japan
Purpose: Inﬂammatory cytokines, such as IL-6, IL-1b and TNF-a play role
of cartilage degeneration in rheumatoid arthritis and osteoarthritis. Intra-
articular injection of hyaluronate is now widely used in the treatment of
osteoarthritis. The main mechanism of HA for the prevention of cartilage
destruction and disease progression is thought to be an action in main-
taining the viscoelastic properties of synovial ﬂuid. In addition to this, we
and others have reported that HA down-regulated the expressions of
cartilage matrix degrading enzymes. In this study, we investigate the
inhibitory mechanism of high molecular weight hyaluronic acid (HA) on
the production of matrix metallopoteinases-3 (MMP-3) and a disintegrin
and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4)
induced by IL-6, IL-1b and TNF-a in human articular chondrocytes.
Methods: Human articular chondrocytes were cultured with IL-6+soluble
IL-6 receptor (sIL-6R), IL-1b or TNF-a in the presence or absence of HA or
extracellular signal-regulated kinase (ERK) inhibitor for 24 h. Moreover,
chondrocyteswere culturedwith cytokineandHA in thepresenceorabsence
of mitogen-activated protein kinase phosphatase (MKP-1) inhibitor for 24 h.
After culture, MMP-3 and ADAMTS-4 mRNA expressions were measured by
